These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22805148)

  • 21. C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.
    Dass CR; Choong PF
    Pharmazie; 2008 Jun; 63(6):411-4. PubMed ID: 18604982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model.
    Dass CR; Khachigian LM; Choong PF
    Mol Cancer Res; 2008 Aug; 6(8):1289-92. PubMed ID: 18708361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-Jun knockdown sensitizes osteosarcoma to doxorubicin.
    Dass CR; Khachigian LM; Choong PF
    Mol Cancer Ther; 2008 Jul; 7(7):1909-12. PubMed ID: 18645001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury. Inhibition by a novel DNA enzyme targeting c-Jun.
    Khachigian LM; Fahmy RG; Zhang G; Bobryshev YV; Kaniaros A
    J Biol Chem; 2002 Jun; 277(25):22985-91. PubMed ID: 11891228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model.
    Dass CR; Friedhuber AM; Khachigian LM; Dunstan DE; Choong PF
    Cancer Biol Ther; 2008 Jul; 7(7):1033-6. PubMed ID: 18414033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of c-jun in human liposarcoma growth: supporting data from clinical immunohistochemistry and DNAzyme efficacy.
    Dass CR; Galloway SJ; Clark JC; Khachigian LM; Choong PF
    Cancer Biol Ther; 2008 Aug; 7(8):1297-301. PubMed ID: 18497564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced retinal microvascular density, improved forepaw reach, comparative microarray and gene set enrichment analysis with c-jun targeting DNA enzyme.
    Chan CW; Kaplan W; Parish CR; Khachigian LM
    PLoS One; 2012; 7(7):e39160. PubMed ID: 22815700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Jun DNAzymes inhibit myocardial inflammation, ROS generation, infarct size, and improve cardiac function after ischemia-reperfusion injury.
    Luo X; Cai H; Ni J; Bhindi R; Lowe HC; Chesterman CN; Khachigian LM
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1836-42. PubMed ID: 19592465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells.
    Tormos C; Javier Chaves F; Garcia MJ; Garrido F; Jover R; O'Connor JE; Iradi A; Oltra A; Oliva MR; Sáez GT
    Cancer Lett; 2004 May; 208(1):103-13. PubMed ID: 15105052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factor c-Jun activation represses mdr-1 gene expression.
    Miao ZH; Ding J
    Cancer Res; 2003 Aug; 63(15):4527-32. PubMed ID: 12907627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. iNOS-targeted 10-23 DNAzyme reduces LPS-induced systemic inflammation and mortality in mice.
    Verma N; Tripathi SK; Chaudhury I; Das HR; Das RH
    Shock; 2010 May; 33(5):493-9. PubMed ID: 19823115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple intracellular signallings are involved in thyrotropin-releasing hormone (TRH)-induced c-fos and jun B mRNA levels in clonal prolactin cells.
    Passegue E; Richard JL; Boulla G; Gourdji D
    Mol Cell Endocrinol; 1995 Jan; 107(1):29-40. PubMed ID: 7796933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization and expression of Jun-like immunoreactivity in apoptotic neurons induced by colchicine administration in vivo and in vitro depends on the antisera used.
    Pozas E; Aguado F; Ferrer I
    Acta Neuropathol; 1999 Aug; 98(2):119-28. PubMed ID: 10442550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene.
    Abshire MK; Buzard GS; Shiraishi N; Waalkes MP
    J Toxicol Environ Health; 1996 Jul; 48(4):359-77. PubMed ID: 8691507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific c-Jun target genes in malignant melanoma.
    Schummer P; Kuphal S; Vardimon L; Bosserhoff AK; Kappelmann M
    Cancer Biol Ther; 2016 May; 17(5):486-97. PubMed ID: 27050748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein.
    Wang Y; Zhang X; Lebwohl M; DeLeo V; Wei H
    Carcinogenesis; 1998 Apr; 19(4):649-54. PubMed ID: 9600350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
    Tan ML; Friedhuber AM; Dass CR
    J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.
    Abbas S; Bhoumik A; Dahl R; Vasile S; Krajewski S; Cosford ND; Ronai ZA
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6769-78. PubMed ID: 18006779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
    Zhang X; Wu J; Luo S; Lechler T; Zhang JY
    Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.